Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Alzheimer Disease 11 | Kisho | Kisho

Back to Alzheimer Disease 11

Alzheimer Disease 11 — NIH Grants & Funding

Active and recent NIH-funded research on Alzheimer Disease 11. Data from NIH RePORTER, last 36 months.

MONDO:0012344

NIH-funded research on Alzheimer Disease 11

active grants

institutions

researchers

new in last 12 mo.

$140.9M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(27)

Basic ScienceRF1Active

Hyperactivity of the thalamo-hippocampal-prefrontal circuit as a mechanism for anxiety in Alzheimer disease - Resubmission - 1

Masurkar, Arjun·NEW YORK UNIVERSITY SCHOOL OF MEDICINE·NEW YORK, NY

$2,044,038 (FY2024)

Alzheimer Disease 11 — NIH Grants & Funding

Basic Science(27)

Hyperactivity of the thalamo-hippocampal-prefrontal circuit as a mechanism for anxiety in Alzheimer disease - Resubmission - 1

Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging

Develop and Validate a Mouse Model for Alzheimer Disease in Down Syndrome

LRP1-tau interactions and Alzheimer Disease

Extracellular vesicle transport of brain-derived proteins to the blood in Alzheimer disease

Differential impact of Alzheimer disease on neuronal subpopulations in dorsal hippocampal CA1

Oligodendrocyte heterogeneity in Alzheimer' s disease

The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease

TREM2-endogenous ligand interactions in Alzheimer disease

Mechanism of CD33 receptor signaling in Alzheimer disease

Translational(5)

Development of a therapeutic nanobody targeting brain TNFa for the treatment of Alzheimer Disease

TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease

Drugs repositioning to target TREM2 in Alzheimer disease

Repurposing drugs for Alzheimer´s disease using a reverse translational approach

Brain extracellular matrix changes during normal aging and in Alzheimer disease

Clinical(5)

Alzheimer Disease Research Center

Escitalopram for Agitation in Alzheimer Disease

In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI

Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease

Neuropathological changes underlying clinical heterogeneity in Alzheimer disease

Epi / Nat. History(5)

Social Networks in Alzheimer Disease 2.0.

Impact of the Human Herpesvirus 6A (HHV6A) latency gene U94A on Alzheimer disease pathology

Understanding Alzheimer disease heterogeneity in Hispanic populations.

The Origins of Alzheimer Disease in African Americans

Optimization of Glutathione Levels and Alzheimer Disease Risk in African Americans

Biomarker / Dx(5)

Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study

In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI

Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease

Soluble TREM2 regulation of microglial function in Alzheimer disease

A novel therapeutic approach for Alzheimer Disease (AD)

Other(3)

Yale Alzheimer Disease Research Center

Super-resolution imaging of brain microvascular changes in a model of Alzheimer Disease

Alzheimer Disease Research Center

TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease